Stay informed Sign up for our newsletter and be the first to know.
Stay informed Sign up for our newsletter and be the first to know.
Brilliant Investment Thinking by Advisers for Advisers.
ASX
-0.70%
S&P
-2.64%
AUD
$0.71

ASX down 0.9%, Bitcoin falls 20%

Blistering start slows, ASX down 0.9%, bond rates higher, Bitcoin falls 20% After a blistering opening to the year in which the ASX200 (ASX:XJO) added 2.6%, attention once again turned to the...
Read More

Australian Unity issues Australian-first MCI

With interest rates at all-time lows, and term deposits lucky to be paying 0.5%, investors have simply been forced to look for alternative income-generating investments. The share market has obliged,...
Read More

ASX struggles under COVID-19 weight

ASX struggles under COVID-19 weight, banks fall, retail sales recover The ASX200 (ASX:XJO) struggled today, falling 1.1%, as concern around the NSW COVID-19 outbreak weighed on sentiment at the same time that volumes fall...
Read More

ASX finishes flat

ASX finishes flat, border closures hit travel, AGL Energy downgrades, weaker open ahead The ASX200 (ASX:XJO) finished flat to begin the week, with news that US politicians finally agreed on a USD$900...
Read More

Winning streak hits seven weeks

Winning streak hits seven weeks, A2 Milk (ASX:A2M) and Mesoblast (ASX:MSB) battered The ASX200 (ASX:XJO) managed to overcome a 1.2% fall to cap off the seventh straight week of gains, adding 0.5%....
Read More

Market update; ASX opens weaker

ASX opens weaker, travel rallies on Tasman bubble, strong open aheadThe ASX 200 (ASX:XJO) finished 0.2% lower to open the week, increasing the likelihood of the first negative month since...
Read More

A Q&A with Luke Laretive

We are pleased to speak with Luke Laretive of Seneca Financial Solutions this week. Luke Laretive must be one of the most prolific sharemarket writers in the market, filling LinkedIn...
Read More

ASX update; COVID-19 impacting Macquarie Group

Vaccine trial restart boosts markets, ASX strength to continue, COVID-19 impacting Macquarie Group A positive lead from Wall Street and news that AstraZeneca plc (NYSE:AZN) had resumed their vaccine trial...
Read More

Not even normal for a crash

Stock markets have crashed, we can be confident of that. History suggests there is no quick recovery from crashes like these, which means lasting consequences for investors.

Read More